Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Combined Anticoagulation and Antithrombotic Therapy vs Antithrombotic Therapy Alone After Lower Extremity Revascularization for Peripheral Arterial Disease

NCT04994223 is registered in ClinicalTrials.gov with Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi as lead sponsor.

NCT NCT04994223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04994223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Combined Anticoagulation and Antithrombotic Therapy vs Antithrombotic Therapy Alone After Lower Extremity Revascularization for Peripheral Arterial Disease
Lead sponsor
Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi
Phase
Phase 1
Overall status
Unknown status
Start date
July 2, 2021
Completion date
December 30, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

combined anticoagulation and antithrombotic therapy, pad - peripheral arterial disease